| Primary |
| B-cell Lymphoma |
48.7% |
| Drug Use For Unknown Indication |
13.2% |
| Product Used For Unknown Indication |
13.2% |
| Asthma |
7.9% |
| Breast Cancer |
2.6% |
| Cryptogenic Organising Pneumonia |
2.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Atrial Fibrillation |
1.3% |
| Chronic Kidney Disease |
1.3% |
| Deep Vein Thrombosis |
1.3% |
| Hiatus Hernia |
1.3% |
| Hypertension |
1.3% |
|
| Pulmonary Embolism |
22.2% |
| Acute Respiratory Distress Syndrome |
11.1% |
| Bronchial Disorder |
11.1% |
| International Normalised Ratio Increased |
11.1% |
| Lung Adenocarcinoma |
11.1% |
| Nausea |
11.1% |
| Pulmonary Alveolar Haemorrhage |
11.1% |
| Thrombocytopenia |
11.1% |
|
| Secondary |
| Rheumatoid Arthritis |
24.8% |
| Drug Use For Unknown Indication |
17.9% |
| Product Used For Unknown Indication |
15.6% |
| Renal Transplant |
7.5% |
| B-cell Lymphoma |
6.7% |
| Behcet's Syndrome |
4.0% |
| Hypertension |
3.8% |
| Acute Lymphocytic Leukaemia |
2.6% |
| Ankylosing Spondylitis |
2.0% |
| Non-hodgkin's Lymphoma |
1.8% |
| Prophylaxis |
1.7% |
| Hiv Infection |
1.5% |
| Crohn's Disease |
1.4% |
| Prostate Cancer |
1.4% |
| Osteoporosis |
1.3% |
| Psoriatic Arthropathy |
1.3% |
| Systemic Lupus Erythematosus |
1.3% |
| Diabetes Mellitus |
1.3% |
| Prophylaxis Against Transplant Rejection |
1.2% |
| Liver Transplant |
1.0% |
|
| Vomiting |
10.2% |
| Osteonecrosis |
9.6% |
| Pyrexia |
7.1% |
| Squamous Cell Carcinoma |
6.6% |
| Thrombocytopenia |
6.0% |
| Tuberculosis |
5.2% |
| Progressive Multifocal Leukoencephalopathy |
4.9% |
| Sepsis |
4.7% |
| Weight Decreased |
4.7% |
| Renal Failure Acute |
4.4% |
| Transplant Rejection |
4.4% |
| Urinary Tract Infection |
4.1% |
| Interstitial Lung Disease |
3.8% |
| Neutropenia |
3.8% |
| Leukocytosis |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Diabetes Mellitus |
3.3% |
| Lung Adenocarcinoma Stage I |
3.3% |
| Pruritus |
3.3% |
| Septic Shock |
3.3% |
|
| Concomitant |
| Rheumatoid Arthritis |
32.6% |
| Drug Use For Unknown Indication |
19.1% |
| Product Used For Unknown Indication |
16.2% |
| Hypertension |
3.9% |
| Renal Transplant |
3.9% |
| Prophylaxis |
3.1% |
| Osteoporosis |
3.0% |
| Pain |
2.7% |
| Crohn's Disease |
2.2% |
| Depression |
1.7% |
| Immunosuppression |
1.5% |
| Ankylosing Spondylitis |
1.5% |
| Prophylaxis Against Transplant Rejection |
1.5% |
| Hiv Infection |
1.3% |
| Anxiety |
1.1% |
| Diabetes Mellitus |
1.0% |
| Lymphoma |
1.0% |
| Systemic Lupus Erythematosus |
0.9% |
| Asthma |
0.9% |
| Non-small Cell Lung Cancer |
0.8% |
|
| Thrombocytopenia |
11.7% |
| Vomiting |
9.9% |
| Pyrexia |
8.1% |
| Renal Failure Acute |
6.8% |
| Renal Failure |
6.0% |
| Weight Decreased |
5.6% |
| Neutropenia |
4.9% |
| Cytolytic Hepatitis |
4.4% |
| Sepsis |
4.2% |
| Weight Increased |
4.2% |
| Rheumatoid Arthritis |
4.1% |
| Tachycardia |
4.0% |
| Toxic Skin Eruption |
4.0% |
| Sinusitis |
3.6% |
| Urinary Tract Infection |
3.4% |
| Tooth Extraction |
3.2% |
| Pancytopenia |
3.1% |
| Tooth Infection |
3.0% |
| Transaminases Increased |
3.0% |
| Rash Maculo-papular |
2.8% |
|
| Interacting |
| Drug Use For Unknown Indication |
19.7% |
| Prophylaxis Against Transplant Rejection |
8.5% |
| Renal Transplant |
8.5% |
| Spinal Compression Fracture |
8.5% |
| Depression |
5.6% |
| Nephrotic Syndrome |
5.6% |
| Prophylaxis |
5.6% |
| Atrial Fibrillation |
4.2% |
| Oesophageal Candidiasis |
4.2% |
| Aspergillosis |
2.8% |
| Atrial Flutter |
2.8% |
| Bronchitis |
2.8% |
| Essential Hypertension |
2.8% |
| Helicobacter Infection |
2.8% |
| Hypercholesterolaemia |
2.8% |
| Hypertension |
2.8% |
| Immune Thrombocytopenic Purpura |
2.8% |
| Optic Neuritis |
2.8% |
| Organ Transplant |
2.8% |
| Erysipelas |
1.4% |
|
| International Normalised Ratio Increased |
15.8% |
| Drug Interaction |
10.5% |
| Hyponatraemia |
10.5% |
| Renal Failure Acute |
10.5% |
| Malaise |
5.3% |
| Melaena |
5.3% |
| Meningorrhagia |
5.3% |
| Presyncope |
5.3% |
| Pulmonary Embolism |
5.3% |
| Rectal Haemorrhage |
5.3% |
| Renal Haemorrhage |
5.3% |
| Transplant Rejection |
5.3% |
| Urticaria |
5.3% |
| Vomiting |
5.3% |
|
